Promising biomarkers of AKI are cystatin C [11], neutrophil gelatinase-associated lipocalin (NGAL) [12], tissue inhibitor of metalloproteinase 2 (TIMP-2), and insulin-like growth factor-binding protein 7 (IGFBP7) [13]. The gene discussed is CST3; the disease is acute kidney injury.